Evidence map›Paper›PMID 34429473›Full record

ArticleScientific reports2021

C. elegans-based chemosensation strategy for the early detection of cancer metabolites in urine samples.

Enrico Lanza, Martina Di Rocco, Silvia Schwartz, Davide Caprini, Edoardo Milanetti, Giuseppe Ferrarese, Maria Teresa Lonardo, Luca Pannone, Giancarlo Ruocco, Simone Martinelli and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. HarnessingSensors (Basel, Switzerland) · 2025
    Review
  5. Article
  6. Review
  7. microPublication biology · 2025
    Article
  8. Article
  9. Article
  10. A non-invasive screening method usingBiochemistry and biophysics reports · 2024
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Biomedicines · 2022
    Review
  19. Article
  20. Non-invasive cancer detection in canine urine throughFrontiers in veterinary science · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Enrico Lanza *Istituto Italiano di Tecnologia, Center for Life Nano Science, Rome, 00161, Italy. enrico.lanza@uniroma1.it.
Martina Di Rocco *Istituto Italiano di Tecnologia, Center for Life Nano Science, Rome, 00161, Italy.
Silvia SchwartzIstituto Italiano di Tecnologia, Center for Life Nano Science, Rome, 00161, Italy.
Davide CapriniIstituto Italiano di Tecnologia, Center for Life Nano Science, Rome, 00161, Italy.
Edoardo MilanettiIstituto Italiano di Tecnologia, Center for Life Nano Science, Rome, 00161, Italy.
Giuseppe FerrareseIstituto Italiano di Tecnologia, Center for Life Nano Science, Rome, 00161, Italy.
Maria Teresa LonardoDepartment of Surgery, Ospedale M. G. Vannini, Rome, 00177, Italy.
Luca PannoneGenetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, RM, 00165, Italy.
Giancarlo RuoccoIstituto Italiano di Tecnologia, Center for Life Nano Science, Rome, 00161, Italy.
Simone MartinelliDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, 00161, Italy.
Viola FolliIstituto Italiano di Tecnologia, Center for Life Nano Science, Rome, 00161, Italy.
Italian Institute of Technology · ITBambino Gesù Children's Hospital · ITIstituto Superiore di Sanità · IT

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
NIH HHS P40 OD010440
6 · The paper itself

Abstract

Chemosensory receptors play a crucial role in distinguishing the wide range of volatile/soluble molecules by binding them with high accuracy. Chemosensation is the main sensory modality in organisms lacking long-range sensory mechanisms like vision/hearing. Despite its low number of sensory neurons, the nematode Caenorhabditis elegans possesses several chemosensory receptors, allowing it to detect about as many odorants as mammals. Here, we show that C. elegans displays attraction towards urine samples of women with breast cancer, avoiding control ones. Behavioral assays on animals lacking AWC sensory neurons demonstrate the relevance of these neurons in sensing cancer odorants: calcium imaging on AWC increases the accuracy of the discrimination (97.22%). Also, chemotaxis assays on animals lacking GPCRs expressed in AWC allow to identify receptors involved in binding cancer metabolites, suggesting that an alteration of a few metabolites is sufficient for the cancer discriminating behavior of C. elegans, which may help identify a fundamental fingerprint of breast cancer.

Indexed as

ChemotaxisAnimalsBiomarkers, TumorBreast NeoplasmsCaenorhabditis elegansCaenorhabditis elegans ProteinsChemoreceptor CellsFemaleHumansReceptors, G-Protein-CoupledBiomarkers, TumorCaenorhabditis elegans ProteinsReceptors, G-Protein-Coupled

Identifiers

PMID34429473
PMCPMC8385061
OpenAlexW3169130065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.